These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33618784)

  • 1. Cost minimization analysis of outpatient parenteral/oral antibiotic therapy at a trauma hospital: Public health system.
    Loesch GH; Cruz JAW; Gasparetto J; Oliveira DDS; Telles JP; Tuon FF
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1445-1450. PubMed ID: 33618784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
    Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
    BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients.
    Beieler AM; Dellit TH; Chan JD; Dhanireddy S; Enzian LK; Stone TJ; Dwyer-O'Connor E; Lynch JB
    J Hosp Med; 2016 Aug; 11(8):531-5. PubMed ID: 27120700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient parenteral antibiotic therapy for the treatment of prosthetic knee and hip infections in Belgium, a cost minimization analysis.
    Debaenst N; Seyler L; Putman K; Van Den Borre I; Vanlauwe J
    Acta Clin Belg; 2022 Feb; 77(1):10-17. PubMed ID: 32484406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT).
    Mirón-Rubio M; Parra Jordán JJ; González Ramallo VJ; Mujal Martínez A; Fernández Muixí J; Iglesias Gallego M; Lucas Núñez MC; Rodado Alabau E; Vidal Perez-Campoamor S; Uría E
    Rev Esp Quimioter; 2023 Jun; 36(3):291-301. PubMed ID: 37017118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
    Dimitrova M; Gilchrist M; Seaton RA
    BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
    Heintz BH; Halilovic J; Christensen CL
    Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
    Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
    Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.
    Sumpter C; Russell CD; Mackintosh C
    Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.
    Partridge DG; O'Brien E; Chapman AL
    Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
    Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
    J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
    Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
    Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.